These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32631973)

  • 1. Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.
    Florenzano P; Jimenez M; Ferreira CR; Nesterova G; Roberts MS; Tella SH; Fernandez de Castro L; Gafni RI; Wolf M; Jüppner H; Gales B; Wesseling-Perry K; Markovich D; Gahl WA; Salusky IB; Collins MT
    J Am Soc Nephrol; 2020 Sep; 31(9):2184-2192. PubMed ID: 32631973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
    Ewert A; Leifheit-Nestler M; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Stangl G; Baur AC; Föller M; Feger M; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Zivicnjak M; Haffner D
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal Consequences of Nephropathic Cystinosis.
    Florenzano P; Ferreira C; Nesterova G; Roberts MS; Tella SH; de Castro LF; Brown SM; Whitaker A; Pereira RC; Bulas D; Gafni RI; Salusky IB; Gahl WA; Collins MT
    J Bone Miner Res; 2018 Oct; 33(10):1870-1880. PubMed ID: 29905968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
    Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
    Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities.
    Kluck R; Müller S; Jagodzinski C; Hohenfellner K; Büscher A; Kemper MJ; Oh J; Billing H; Thumfart J; Weber LT; Acham-Roschitz B; Arbeiter K; Tönshoff B; Hagenberg M; Kanzelmeyer N; Pavičić L; Haffner D; Zivicnjak M
    J Inherit Metab Dis; 2022 Mar; 45(2):192-202. PubMed ID: 34989402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis.
    Sansanwal P; Li L; Sarwal MM
    J Am Soc Nephrol; 2015 Mar; 26(3):612-25. PubMed ID: 25071085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
    van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
    Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.
    Machuca-Gayet I; Quinaux T; Bertholet-Thomas A; Gaillard S; Claramunt-Taberner D; Acquaviva-Bourdain C; Bacchetta J
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.
    Bertholet-Thomas A; Claramunt-Taberner D; Gaillard S; Deschênes G; Sornay-Rendu E; Szulc P; Cohen-Solal M; Pelletier S; Carlier MC; Cochat P; Bacchetta J
    Pediatr Nephrol; 2018 Jul; 33(7):1165-1172. PubMed ID: 29435659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 and the PTH response to paricalcitol in chronic kidney disease.
    D'Arrigo G; Pizzini P; Cutrupi S; Tripepi R; Tripepi G; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2020 Feb; 50(2):e13196. PubMed ID: 31863599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.
    Desjardins L; Liabeuf S; Renard C; Lenglet A; Lemke HD; Choukroun G; Drueke TB; Massy ZA;
    Osteoporos Int; 2012 Jul; 23(7):2017-25. PubMed ID: 22109743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary nephrocalcinosis in nephropathic cystinosis.
    Theodoropoulos DS; Shawker TH; Heinrichs C; Gahl WA
    Pediatr Nephrol; 1995 Aug; 9(4):412-8. PubMed ID: 7577398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p62/SQSTM1 prominently accumulates in renal proximal tubules in nephropathic cystinosis.
    Sansanwal P; Sarwal MM
    Pediatr Nephrol; 2012 Nov; 27(11):2137-2144. PubMed ID: 22714671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.